Search Results Search Sort by RelevanceMost Recent State of the Art and Science May 2016 International Access to Clinical Ethics Consultation via Telemedicine Katrina A. Bramstedt, PhD, MA Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations. AMA J Ethics. 2016;18(5):521-527. doi: 10.1001/journalofethics.2016.18.5.stas2-1605. Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76. Viewpoint Nov 2002 Cultural Differences Intensify End-of-life Care Challenges Linda MacDonald Glenn, LLM and Faith Lagay, PhD Virtual Mentor. 2002;4(11):341-344. doi: 10.1001/virtualmentor.2002.4.11.elce1-0211. Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145. Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
State of the Art and Science May 2016 International Access to Clinical Ethics Consultation via Telemedicine Katrina A. Bramstedt, PhD, MA Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations. AMA J Ethics. 2016;18(5):521-527. doi: 10.1001/journalofethics.2016.18.5.stas2-1605.
Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76.
Viewpoint Nov 2002 Cultural Differences Intensify End-of-life Care Challenges Linda MacDonald Glenn, LLM and Faith Lagay, PhD Virtual Mentor. 2002;4(11):341-344. doi: 10.1001/virtualmentor.2002.4.11.elce1-0211.
Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145.
Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?”
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483.